Spatial navigation deficits in amnestic mild cognitive impairment with neuropsychiatric comorbidity by Keynejad, Roxanne C et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1080/13825585.2017.1290212
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Keynejad, R. C., Marková, H., Šiffelová, K., Kumar, N., Vlek, K., Laczó, J., ... Kopelman, M. D. (2017). Spatial
navigation deficits in amnestic mild cognitive impairment with neuropsychiatric comorbidity. Aging,
Neuropsychology and Cognition, 1-13. https://doi.org/10.1080/13825585.2017.1290212
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
1 
 
Title: Spatial navigation deficits in amnestic mild cognitive 
impairment with neuropsychiatric co-morbidity 
Running head: Spatial navigation in aMCI with comorbidity 
 
Corresponding Authors: Roxanne C. Keynejad1, Department of Psychological Medicine, 3rd Floor, 
Adamson Centre for Mental Health, South Wing, St Thomas’s Hospital, London SE1 7EH, UK, and 
Hana Marková2,3, Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol 
University Hospital, V Uvalu 84, 150 06, Prague, Czech Republic. 
 
Roxanne C. Keynejad1, +442078480138, roxanne.keynejad@kcl.ac.uk  
Hana Marková 2, 3, +420224436890, hana@markovaa.cz    
Kamila Šiffelová 2, +420224436890, ksiffelova@seznam.cz   
Naveen Kumar 1, +442078480138, naveen.kumar@kcl.ac.uk  
Kamil Vlček 4, +420224436890, kamil.vlcek@fgu.cas.cz  
Jan Laczó 2, 3, +420224436860, janlaczo@seznam.cz  
Ellen M. Migo 1, +4402071880202, ellen.migo@kcl.ac.uk  
Jakub Hort 2, 3, +420224436860, jakub.hort@gmail.com  
Michael D. Kopelman 1, +4420 7188 0207, michael.kopelman@kcl.ac.uk  
 
1 King’s College London, Institute of Psychiatry, Psychology and Neuroscience, UK. 
2 Memory Clinic, Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol 
University Hospital, Prague, Czech Republic. 
3International Clinical Research Center, St Anne´s University Hospital Brno, Brno, Czech Republic. 
4Department of Neurophysiology of Memory, Institute of Physiology, Academy of Sciences of the 
Czech Republic, Prague, Czech Republic. 
2 
 
Funding and grant-awarding bodies 
Professor Kopelman is supported by the Biomedical Research Centre, KCL. 
This work was supported by the <Charles University in Prague Grant Agency> under Grant <numbers 
135215 and 308216>; the <project no. LQ1605 from the National Program of Sustainability II (MEYS 
CR) >; the <European Regional Development Fund - Project FNUSA-ICRC> under Grant <number 
CZ.1.05/1.1.00/02.0123 (OP VaVpl)>; the <project ICRC-ERA-HumanBridge> under Grant <number 
316345>; the <Ministry of Health, Czech Republic– conceptual development of research 
organization, University Hospital Motol, Prague, Czech Republic> under Grant  <number 00064203>;  
the < Institutional Support of Laboratory Research> under Grant  <number 2/2012 (699002)>; the < 
Institutional Support of Excellence>; the <Research Project > under Grant  <number RVO:67985823>; 
and the <Charta 77 Foundation - Kontro BARIERY scholarship fund Neuro-Euro>.  
 
Disclosure statement 
Other coauthors declare that they have no commercial or financial relationships, which could be 
construed as a potential financial conflict of interest, or benefits arising from the direct applications 
of the research.  
 
Word count 
4078 words, excluding title page, references and tables. 
  
3 
 
Abstract 
Aims: To find out whether neuropsychiatric comorbidity (comMCI) influences spatial navigation 
performance in amnestic mild cognitive impairment (aMCI). 
Methods: We recruited aMCI patients with (n=21) and without (n=21) neuropsychiatric comorbidity 
or alcohol abuse, matched for global cognitive impairment and cognitively healthy elderly 
participants (HE, n=22).  They completed the Mini-Mental State Examination and a virtual Hidden 
Goal Task in egocentric, allocentric and delayed recall subtests. 
Results: In allocentric navigation, aMCI and comMCI performed significantly worse than HE and 
similarly to each other. Although aMCI performed significantly worse at egocentric navigation than 
HE, they performed significantly better than patients with comMCI. 
Conclusions: Despite the growing burden of dementia and the prevalence of neuropsychiatric 
symptoms in the elderly population, comMCI remains under-studied. Since trials often assess “pure” 
aMCI, we may underestimate patients’ navigation and other deficits. This finding emphasizes the 
importance of taking account of the cognitive effects of psychiatric disorders in aMCI.  
 
Keywords:  Mild Cognitive Impairment; neuropsychiatric comorbidity, spatial navigation; spatial 
memory  
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Introduction 
Spatial navigation is often defined as a process of determining and maintaining a trajectory from 
one place to another (Ségoléne, Dufour, & Després, 2012). Two types of navigational strategies are 
distinguished, with evidence of distinct underlying brain structures: egocentric and allocentric 
navigation (Morris, Garrud, Rawlins, & O’Keefe, 1982; Chersi & Burgess, 2015).  Egocentric 
navigation is self-centered, viewpoint-dependent navigation, associated with response learning from 
one’s own position. It uses distances or angles to and from individual landmarks, is associated with 
navigation of well-known paths, and is thought to rely on parietal-cortical and striatal brain regions 
(Wolbers, Weiller, & Büchel, 2004). Allocentric navigation is independent of the individual’s 
viewpoint, referring instead to distal cues.  It encompasses the spatial layout of an environment 
from a survey or “bird’s eye view” perspective, learning the position of landmarks in relation to 
other landmarks. Allocentric navigation relies on the medial temporal lobe, particularly the 
hippocampus (Burgess, Maguire, & O’Keefe, 2002); more recent studies have demonstrated a 
correlation between basal forebrain volume and spatial accuracy in allocentric but not egocentric 
navigation (Kerbler et al., 2015). 
The Morris water maze is a classic test used to study spatial learning and memory in rats 
(Morris, 1981), who learn to find a hidden platform under the surface of a pool, using visual cues 
placed around the room. Successful completion of the Morris water maze is highly sensitive to 
hippocampal damage. The Hidden Goal Task (HGT) is a human analogue of Morris water maze, of 
which real-world and virtual versions exist (Kalova, Vlček, Jarolimova, & Bureš, 2005). Studies using 
the HGT have demonstrated spatial navigation impairment in patients diagnosed with Alzheimer’s 
disease and mild cognitive impairment of different sub-types (Hort, et al., 2007; Laczó et al., 2009), 
when compared with cognitively healthy control participants.   
Amnestic mild cognitive impairment (aMCI) is characterized by memory deficits beyond those 
expected for normal aging, which may be selective (single-domain aMCI) or accompanied by deficits 
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in at least one other cognitive domain, such as language, attention, executive function or 
visuospatial skills (multiple-domain aMCI), and is associated with an elevated risk of developing 
Alzheimer’s disease (Petersen, 2004). Spatial navigation impairment is an early feature of 
Alzheimer’s disease (Henderson, Mack, & Williams, 1989; Hort et al., 2007) and may result from 
hippocampal atrophy, which is also observed in aMCI (Shi et al., 2009).   
Different sub-tests of the HGT can be used to assess egocentric and allocentric navigation. Using 
both virtual and real-world formats, differential patterns of spatial navigation deficits have been 
demonstrated in patients with multiple-domain aMCI and those with single-domain aMCI (Hort et 
al., 2007). Both real-space and computerized versions of the HGT reliably identify aMCI (Laczó et al., 
2012) and it is sensitive enough to detect disease progression in the clinical setting (Laczó et al., 
2009). A recent functional imaging study found that in comparison to controls, patients with aMCI 
showed reduced activity in the hippocampus bilaterally, retrosplenial cortex and left dorsolateral 
prefrontal cortex during a virtual reality analogue of the radial arm maze, despite relatively normal 
task performance (Migo et al., 2016). Increased right dorsolateral prefrontal cortex activity in aMCI 
patients was thought to indicate a potential mechanism to compensate for underactivity in other 
brain regions.  
Mild cognitive impairment can often be accompanied by other neuropsychiatric conditions but 
such patients are usually excluded from research participation (Stephan, Brayne, Savva & Matthews, 
2011). Whilst there is evidence that psychiatric disorders, such as depression, anxiety, and alcohol 
use also affect spatial cognition (see below), the effect of these neuropsychiatric comorbidities on 
spatial navigation is under-researched, especially in humans. Moreover, the presence of these 
neuropsychiatric complaints can result in missed or erroneous diagnoses in the clinical setting. 
The role of the hippocampus in the etiology of neuropsychiatric disorders such as depression is 
an area of growing research interest (Sahay & Longmore, 2007). Spatial memory, a key component 
of spatial navigation, has been demonstrated to be significantly poorer in depressed patients when 
compared to healthy controls using a novel virtual reality navigation task (Gould, Holmes, Fantie, 
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Luckenbaugh, Pine, et al., 2007), whilst a virtual Morris water maze task showed impaired allocentric 
spatial navigation in depressed patients (Cornwell et al., 2010). Such spatial navigation deficits in 
depressed patients have been linked to hippocampal structural and functional abnormalities 
(Campbell, Marriott, Nahmias, & MacQueen, 2004; Videbech, & Ravnkilde, 2004). 
A number of studies have reported multiple-domain cognitive impairment in patients with 
alcohol dependence syndrome during short-term abstinence, with spatial processing deficits most 
common (Knight & Longmore, 1994; Ceccanti et al., 2015). Selective spatial processing deficits seem 
to remain even after long-term abstinence in middle-aged patients after recovery from alcohol 
dependence (Fein, Torres, Price, & Sclafani, 2006). However, no deficits in spatial processing were 
found in long-term abstinent elderly patients after recovery from alcohol dependence, relative to 
age- and gender- comparable light or non-drinking controls (Fein, & McGillivray, 2007). The direct 
impact of chronic alcohol misuse on spatial navigation in humans is under-researched, despite 
inconsistent findings about the effect of alcohol consumption on spatial navigation in rodents 
(Matthews, Simson, & Best, 1996; Santín, Rubio, Begega, & Arias, 2000; Steigarwald & Miller, 1997).    
The aim of this study was to characterize spatial navigation deficits in patients with amnestic 
mild cognitive impairment and a neuropsychiatric co-morbidity (depression, anxiety and history of 
alcohol abuse: comMCI) compared with amnestic MCI without neuropsychiatric co-morbidity (aMCI) 
and healthy controls. For this purpose, we used the Hidden Goal Task (HGT), a human analogue of 
the Morris water maze, to assess spatial navigation performance.  
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Method 
Participants 
A total of 65 patients without a diagnosis of dementia were recruited from St Thomas´ Hospital 
Neuropsychiatry and Memory Disorders Clinic, London, United Kingdom (UK), and from Motol 
University Hospital Memory Clinic, Prague, Czech Republic (CZ). The sample comprised 21 patients 
with aMCI and co-morbid mood disorder or alcohol abuse (comMCI), 21 patients with aMCI without 
neuropsychiatric co-morbidity, and 22 cognitively healthy elderly (HE) participants. 
ComMCI and aMCI participants were referred to specialist clinics by general practitioners, 
neurologists, psychiatrists, and geriatricians based on cognitive complaints reported by the patient 
or the caregiver. HE participants were recruited from the University of the Third Age, an educational 
institution for older adults, and relatives of patients. 
A neuropsychiatrist (UK site) or a cognitive neurologist (CZ site) together with a clinical 
neuropsychologist evaluated each participant in a consensus diagnostic session incorporating the 
patient’s medical history, collateral history from a knowledgeable informant, neuropsychological 
testing, and neuroimaging. 
 
Inclusion and Exclusion Criteria 
Inclusion criteria for aMCI were age between 55 and 80 and cognitive deficit meeting 
established revised clinical criteria (Petersen, 2004; Table 1).  Participants assigned to the comMCI 
group met criteria for aMCI and had a clinical history of mood, psychotic disorder or schizoaffective 
disorder, or history of alcohol abuse (daily alcohol consumption >40 g for women and > 80 g for 
men).  The corresponding ICD-10 categories for comorbidities were F32: depressive episode, F20: 
schizophrenia, F25: schizoaffective disorders, F41: other anxiety disorders and F10.1: mental and 
behavioral disorders due to use of alcohol: harmful use. The HE group comprised participants 
reporting no subjective cognitive difficulties, who did not score lower than 1.5 standard deviations 
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below mean age- and education-adjusted norms on neuropsychological tests of working memory, 
episodic memory, executive function, language, and visuospatial skills.  
Consenting participants were assigned to groups using a combination of their clinical history, 
clinically performed neuropsychological assessments, and Beck anxiety and/or depression scores, 
where available. Verbal recall, visual recall and executive function had been measured during clinical 
assessments across the two sites, but using different rating scales. Raw scores were therefore 
converted to Z-scores at each site. Depressive symptoms were measured using the Beck Depression 
Inventory (BDI-II; UK site) and the 15 item Geriatric Depression Scale (GDS-15; CZ site). Scores on 
each measure were categorized for severity of depression according to published norms. 
 
Table 1 
 
Exclusion criteria were current acute psychotic episode, acute major depressive episode, acute 
intoxication during assessment, severe visual and auditory impairment, a history of stroke, severe 
cranio-cerebral trauma, epilepsy, multiple sclerosis, or non-cooperation.  
Participant groups were matched, based on age, Mini-Mental State Examination (MMSE) score 
and years in education (Table 2). 
 
 Ethics 
Ethical approval for UK recruitment was obtained from the Camberwell St Giles Research Ethics 
Committee (ref:13/LO/1101). Ethical approval for CZ recruitment was obtained from the Motol 
University Hospital Ethics Committee. All participants gave written, informed consent.  
 
Procedure 
An initial interview obtained demographic information about the participant’s age, education 
and subjective difficulties with spatial navigation. Participants then completed the computerized 
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Hidden Goal Task (HGT) and an MMSE (Folstein, 1975) to screen for the severity of any cognitive 
impairment, before the delayed recall (allocentric) subtest of the HGT.  
The HGT is a well-validated method designed to measure egocentric and allocentric navigation 
(Kalova, Vlček, Jarolimova, & Bureš, 2005). Participants were required to learn where a goal (small 
purple circle, 10 arbitrary units in diameter) was located within an “arena” (larger white circle, 280 
arbitrary units in diameter), by using its relationship to the starting point’s position (filled red circle 
outside the arena) and the orientation cues (red and green lines parallel to the arena’s contour) and 
try to find it again when it was hidden. They did so by dragging the cursor from the starting point to 
its anticipated location.  
Participants were required to locate a hidden goal in three different subtests of the HGT (Figure 
1): egocentric (using the starting point’s position for orientation), allocentric (using external 
orientation cues) and delayed recall (allocentric). The process was demonstrated by the researcher 
before trials began, for each subtest.  
Egocentric and allocentric subtests featured eight trials. The configuration of the starting point, 
orientation cues, and goal remained the same during the task, and was displayed on a 
demonstration screen once before testing commenced. During each trial, the screen image rotated 
into different positions, equally spaced around the arena in a fixed order. Before each trial, the 
participant was reminded to locate the goal in its position, relative to the starting point or 
orientation cues (depending on the subtest). After the participant had selected the location of the 
hidden goal, its correct position was displayed, and he or she was reminded to take note of its 
relative position to the starting point and orientation cues, if present.  
The delayed recall subtest was similar to the allocentric subtest but consisted of only two trials 
administered 30 minutes after the end of the allocentric subtest, in which the correct goal position 
was not displayed. 
There was no time limit to locate the goal. The outcome measure was the distance error from 
the goal in pixels, where a smaller number indicated better performance. 
10 
 
A                                    B1                     B2 
                              
 
Figure 1: Hidden Goal Task Screens: (A) Arena (large white circle) as displayed on the demonstration screen 
before testing, with starting point (red filled circle), orientation cues (red and green lines) and goal (purple 
circle) marked; (B1) Egocentric trial; (B2) Allocentric trial. 
 
 Analysis 
The distances between participants’ selected location for the hidden goal and its true location 
were used to calculate mean distance errors for each individual and then group. As the assumption 
of normality was not breached (values of skewness and curtosis ranged from -1 to +1), we 
performed a parametric one-way ANOVA, with Tukey post hoc test, to evaluate between-groups 
differences in demographic characteristics, and mean distance errors in egocentric, allocentric and 
delayed recall subtests. To compare background neuropsychological characteristics between the two 
patient groups (aMCI and comMCI), raw scores for visual recall, verbal recall and executive function 
available across both sites were converted to Z-scores according to published age- and education-
adjusted norms. As the assumption of normality had been breached (values of skewness and curtosis 
ranged outside -1 to +1), Z-scores were compared using the non-parametric Mann-Whitney U test. 
The independent samples T-Test was additionally performed, for confirmation. To report effect 
sizes, Cohen’s d was calculated. Depressive symptoms were categorized as minimal, mild, moderate 
or severe, according to published norms for each rating scale.  The two patient groups (aMCI and 
comMCI) were compared in terms of severity of depression across these categories using the Chi-
Square test.  
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The rank-based nonparametric Kruskal-Wallis H Test was performed to determine if there were 
statistically significant differences in egocentric, allocentric and delayed recall performance between 
comMCI participants with different comorbid clinical diagnoses. The significance level (alpha) 
throughout the analyses was set at .05. All statistics analyses were run using SPSS Statistics 20 for 
Windows.  
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Results  
Demographic characteristics  
All groups were well matched on background demographic characteristics (Table 2). There were 
no group differences in age, F (2, 61) = 2.54, MSE = 66.02, p = .087, or years of education, F (2, 61) = 
1.87, MSE = 12.49, p = .163. However, as expected, there was a significant main effect of group on 
MMSE, F (2, 61) = 10.79, MSE = 6.90, p < .001. Tukey post hoc tests indicated that aMCI and comMCI 
scored less than HE (ps ≤ .001; d = 1.32 and d = 1.34, respectively) but they were not significantly 
different from each other (p = .827; d = .13). There was no significant difference between aMCI and 
comMCI on any background neuropsychological measure (Table 3), nor in the severity of depression 
according to published categories of depressive symptom severity, χ2(3) = 3.17, p = .37. comMCI 
patients had diagnoses of aMCI with comorbid clinical diagnoses of depression (10), anxiety (4), 
mixed anxiety and depression (4) and alcohol misuse (3).  
 
Table 2 
Table 3 
Mean Distance Errors 
We calculated mean distance errors for each group’s performance on each subtest of the HGT 
(Table 4; Figure 2).  
Table 4 
 
Significant differences in mean distance errors were present across groups in egocentric, F (2, 61) = 
17.00, MSE = 993.24, p < .001, and allocentric subtests, F (2, 61) = 17.02, MSE = 1114.07, p < .001. In 
the egocentric subtest, comMCI and aMCI groups were impaired relative to HE participants (p < 
.001; d = 2.19 and p = .006; d = 1.03; respectively), but aMCI performed significantly better than 
comMCI (p = .034; d = .65). In the allocentric subtest, both comMCI and aMCI groups were impaired 
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in comparison to HE participants (both ps < .001; d = 1.72 and d = 1.53, respectively), but aMCI 
performed similarly to comMCI (p = .554; d = .28).  In the delayed recall subtest, there were 
significant group differences in mean distance errors, F (2, 57) = 12.11, MSE = 2039.93, p < .001, with 
both comMCI and aMCI impaired relative to HE (p = .001; d = 1.20 and p < .001; d = 1.68; 
respectively) but there was no difference between comMCI and aMCI groups (p = .784; d = .18). In 
summary, aMCI and comMCI groups performed significantly worse than controls in all conditions. 
The comMCI and aMCI groups differed on the egocentric subtest, where comMCI participants 
performed significantly worse. Interpretation of differences in mean distance errors by comorbidity 
was limited by sample size. There was an indication that errors were lower in participants with 
comMCI and anxiety disorder than in those with comMCI and depression, depression and anxiety or 
alcohol misuse (Supplementary Table 1). However, Kruskal-Wallis H Tests showed no statistically 
significant differences in performance between comMCI sub-groups across HGT subtests, egocentric: 
χ2(3) = 1.147, p = .766, allocentric: χ2(3) = 4.582, p = .205, and delayed recall: χ2(3) = .655, p = .884. 
 
Figure 2: Mean distance errors by group in each Hidden Goal Task (HGT) subtest. Asterisks represent 
significant differences (p < .05) from HE group. Star represents a significant difference between aMCI and 
comMCI 
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Discussion  
As expected, there were significant differences in egocentric and allocentric navigation between 
healthy elderly participants, patients with aMCI and patients with comMCI. In viewpoint-dependent 
egocentric navigation, patients with aMCI performed significantly worse than healthy controls but 
significantly better than patients with comMCI, despite comparable background neuropsychological 
and depression scores between the two MCI groups. On viewpoint-independent allocentric 
navigation and delayed recall (also allocentric), patients with aMCI and comMCI did not differ 
significantly from each other, but both performed significantly worse than healthy controls. This 
indicates that aMCI with comorbid neuropsychiatric disorder was associated with significantly worse 
egocentric but not allocentric navigation than the ‘aMCI alone’ group.  
Previous research has suggested that egocentric navigation relies on cortico-striatal brain 
regions (Wolbers et al., 2004) and allocentric navigation on the medial temporal lobes (Burgess et 
al., 2002) and basal forebrain (Kerbler et al., 2015). This raises the possibility that comorbid 
neuropsychiatric disorders may interact with aMCI to differentially affect spatial cognition and 
potentially its underlying neurocircuitry. Egocentric navigation is relatively more preserved than 
allocentric navigation in individuals with aMCI (Hort et al. 2007), which could explain comparatively 
better performance in participants with aMCI without comorbid neuropsychiatric disorders than 
those with comMCI. Participants with aMCI commonly progress to Alzheimer´s dementia (Albert et 
al., 2011). Disruption of the cholinergic system is an early neuropathological hallmark of Alzheimer´s 
disease (Schliebs & Arendt, 2011) and may also underlie spatial navigation deficits in aMCI (Kerbler 
et al., 2015). In comorbid neuropsychiatric disorders, more extensive disruption of 
neurotransmission systems is present, encompassing serotonin and dopamine mediators (Gordon & 
Hen, 2004; Kapur & Mann, 1992; Mann, 1999; Noble, 1996). These mediators have a reported role in 
the regulation of cognitive processes (Olvera-Cortés, Anguiano-Rodríguez, López-Vázquez, & Alfaro, 
2008). This may result in more complex deficits in spatial navigation and explain the more profound 
egocentric navigation impairment in participants with comMCI, compared to aMCI. It is also possible 
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that there are underlying neuroanatomical differences, despite similar levels of cognitive 
impairment to those with aMCI. This would require a study involving neuroimaging to examine this 
hypothesis. The similarity between aMCI and comMCI groups on the allocentric subtest could have 
resulted from both groups’ distance errors approaching the limits of arena size. It would therefore 
be of interest to repeat this study with more extensive neuropsychological assessments, and/or with 
functional neuroimaging to visualize brain regions active during the performance of each subtest, 
and on easier tests of allocentric navigation. 
 
Because of the relatively small numbers of participants with different neuropsychiatric 
conditions, detailed comparison between spatial navigation performance of sub-groups was limited. 
Although there were no significant differences in performance between comMCI sub-groups across 
HGT sub-tests, there was a trend for better performance in participants with comorbid anxiety than 
in those with depression, mixed depression and anxiety or alcohol abuse. Based on previous 
literature, we might have expected these sub-groups to differ, with more profound spatial 
navigation impairment in participants with depression and alcohol dependence anticipated than in 
those with anxiety disorder. 
Whilst multiple-domain cognitive impairment in patients with depression or alcohol 
dependence is already well-established, their spatial navigation performance on complex tasks, such 
as the HGT, may be modulated by different processes. In animal studies of ethanol consumption, 
both mild thiamine deficiency and chronic alcohol intake have been shown to modulate spatial 
memory performance on the Morris water maze, and the activity of acetylcholinesterase (Oliveria-
Silva et al., 2015). Studies using alternative tasks to the HGT have established impaired spatial and 
temporal order recall in participants with alcohol-induced Korsakoff Syndrome (Kopelman, 
Stanhope, and Kingsley, 1997; Kessels, Postma, Wijnalda, and de Haan, 2000; Postma, van Asselen, 
Keuper, Wester, and Kessels, 2006). Similar profiles of episodic and working memory deficits have 
been demonstrated in participants with alcohol dependence with and without a diagnosis of 
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Korsakoff’s syndrome (Pitel et al., 2008). A review identified that participants diagnosed with 
Korsakoff’s syndrome demonstrate impaired explicit processing of contextual (spatial and temporal) 
information and in binding of target to contextual information in long-term and working memory 
(Kessels & Kopelman, 2012). 
A study of healthy participants found that experimentally-induced anxiety enhanced spatial 
navigation performance on a virtual Morris water maze task, associated with increased left posterior 
hippocampal theta rhythm activity on magnetoencephalography (MEG; Cornwell et al., 2012). 
Despite growing interest in hippocampal function in specific conditions such as post-traumatic stress 
disorder (Karl et al., 2006), there is a paucity of studies of spatial navigation in anxiety disorders 
more generally. There is evidence to suggest that symptoms of anxiety but not depression affect 
subjective spatial navigation complaints in elderly individuals, irrespective of objective spatial 
navigation performance (Sheardova et al., 2015). Moreover, in a study demonstrating impaired 
allocentric navigation in depressed patients using a virtual Morris water maze task, 47% had a 
current anxiety disorder, complicating interpretation of differences in hippocampal activity 
(Cornwell et al., 2010). It will therefore be important that future studies systematically assess for 
individual neuropsychiatric disorders to investigate their relationship to spatial navigation deficits 
and complaints. 
The burden of dementia is growing (Alzheimer’s Society, 2014; Czech Alzheimer’s Society, 2015) 
and the current cost to the United Kingdom is £26.3 billion per year. Clinically significant psychiatric 
symptoms are more prevalent in older adults than discrete psychiatric disorders, with sleep 
difficulties, anxiety disorders and depression the most common (Hybels & Blazer, 2015; Kopelman & 
Crawford, 1996). There is a higher than expected frequency of binge drinking among older adults 
(Blazer & Wu, 2011) and suicide rates are higher in older men, especially of white ethnicity in 
American samples (Hybels & Blazer, 2015). Despite the burden of both dementia and psychiatric 
symptoms in older adults, specific effects on spatial navigation of comorbid neuropsychiatric 
disorders in the context of aMCI have not been well-studied. Patients with comorbid psychiatric 
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disorders are frequently excluded from dementia research due to concerns about confounding 
effects (Stephan et al., 2011), but this limits the generalizability of findings to the clinical population, 
in whom comorbidity is the norm rather than the exception. 
A strength of this study was its use of the HGT, a validated human analogue of the Morris water 
maze, frequently used to assess spatial navigation in animals. This behavioral test enables 
comparison between human and animal study findings and generation of hypotheses which can be 
tested in both groups. However, our findings are limited by sample size and use of only the MMSE 
(within the study itself) to quantify cognitive impairment. Because clinical data were gathered at two 
different memory clinics using different background neuropsychological batteries, the interpretation 
of our findings was limited. Our comMCI group was selected for clinical evidence of comorbid 
depression, anxiety or alcohol misuse. However, cases of acute depression were excluded, and this 
may explain why, on the rating scales, aMCI and comMCI groups did not differ significantly in terms 
of the proportion of patients falling in the different categories of depression severity. Replication in 
a larger cohort with detailed neuropsychological assessment, and the use of consistent clinical 
assessment and rating scales across sites to evaluate current and lifelong mental health problems, 
would enhance our understanding of the interactions between aMCI and comorbid neuropsychiatric 
disorders. Expansion of this research to include functional neuroimaging might further elucidate the 
neuroanatomical processes underlying egocentric and allocentric navigation in patients with 
comMCI and aMCI alone.  
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Conclusions 
Despite the growing burden of dementia and the prevalence of psychiatric symptoms in the 
elderly population, spatial navigation has not previously been compared in patients with aMCI and 
comMCI. Our study indicated worse egocentric navigation in patients with comMCI in comparison to 
patients with aMCI only, despite similar levels of global cognitive impairment. These findings 
highlight the additional problems experienced by patients with concomitant psychiatric disorder, as 
well as the need for further research examining the nature of spatial navigation impairment in 
comMCI. Since trials often assess ‘pure’ aMCI only, we may underestimate navigation and other 
deficits, for which support may be needed. Future research might involve a larger sample size, 
perhaps including neuroimaging techniques to visualize affected brain regions. 
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Tables 
 
Table 1: Inclusion criteria for amnestic Mild Cognitive Impairment (aMCI) 
aMCI criteria (Petersen, 2004) 
1. Memory complaint usually corroborated by an informant 
2. Objective memory impairment for age 
3. Essentially preserved general cognitive function 
4. Largely intact functional activities 
5. Not dementia 
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Table 2: Demographic characteristics of the sample: Means (Standard Deviations in brackets) 
 HE comMCI d1 aMCI d1 d2 
N 22 (6 male) 21 (12 male)  21 (8 male)   
Age  65.8 (6.4) 62.5 (7.6) .47 68.1 (10.1) .27 .63 
Education 15.8 (2.7) 14.0 (4.1) .52 14.1 (3.7) .52 .03 
MMSE 29.1 (1.4) 25.7 (3.3)** 1.34 26.1 (2.9)** 1.32 .13 
** p ≤ 0.001: Tukey post hoc significance compared to HE (One-Way ANOVA); d: Cohen´s d effect size: 
1
 in 
comparison to HE, 
2
 in comparison to comMCI. 
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Table 3: Background neuropsychological data comparisons (comMCI and aMCI) 
Cognitive fiction Mean (Standard Deviation) 
Mann-Whitney 
U test 
T-test  
 comMCI aMCI U P t p d 
Verbal recall‡ -1.43 (.89) -1.13 (1.18) 147.50 .359 -.89 .377 .29 
Visual recall‡‡ -1.01 (1.05) -1.16 (.92) 176.00 .941 .48 .635 .15 
Executive function‡‡‡ 
(composite score) 
-1.08 (.86) -1.00 (1.08) 156.00 .509 -.25 .803 .08 
      
‡ 
UK site – Doors and People (D&P), CZ site – Rey Auditory Verbal Learning Test (RAVLT), recall of the first trial; 
‡‡ 
UK site – D&P, CZ site – Rey-Osterrieth Complex Figure, recall after three minutes; 
‡‡‡ 
UK site – mean of Z-
scores from FAS test, Hayling and Brixton tests, error score; CZ site – mean of Z-scores from FAS test (Czech 
version, letters N, K, P), Trail Making Test, part B; d: Cohen´s d effect size. 
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Table 4: Distance errors throughout HGT subtests: Means (Standard Deviations in brackets) 
** p ≤ .001, * p ≤ .01: Tukey post hoc significance compared to HE; † p ≤ .05: Tukey post hoc significance 
compared to comMCI; d: Cohen´s d effect size: 
1
 in comparison to HE, 
2
 in comparison to comMCI. 
 
 HE (n=22) comMCI (n=21) d1 aMCI (n=21) d1 d2 
Egocentric 25.8 (8.2) 81.7 (35.1)** 2.19 56.8 (41.6)* † 1.03 .65 
Allocentric 39.4 (21.8) 95.2 (40.4)** 1.72 84.5 (35.6)** 1.53 .28 
Delayed Recall 31.8 (20.8) 85.7 (59.8)** 1.20 95.5 (49.5)** 1.68 .18 
28 
 
Supplementary Table 1: Distance errors throughout HGT subtests in comMCI subgroups: Means (Standard 
Deviations in brackets) 
 comMCI 
depression 
(n=10) 
comMCI 
anxiety 
(n=4) 
comMCI 
depression + anxiety 
(n=4) 
comMCI 
alcohol 
(n=3) 
MMSE 25.0 (3.1) 28.5 (1.3) 23.3 (4.1) 27.3 (1.2) 
Egocentric 83.7 (40.5) 64.9 (39.4) 85.5 (28.9) 92.5 (23.9) 
Allocentric 92.6 (37.8) 67.0 (39.3) 115.7 (53.5) 114.1 (16.5) 
Delayed Recall 86.2 (56.9) 63.7 (38.4) 86.6 (95.7) 112.7 (75.0) 
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Figure captions 
 
Figure 1: Hidden Goal Task Screens: (A) Arena (large white circle) with start point (red filled circle), 
orientation cues (red and green lines) and goal (purple circle) marked; (B1) Egocentric trial; (B2) 
Allocentric trial. 
 
Figure 2: Mean distance errors by group in each Hidden Goal Task (HGT) subtest.  
 
 
